Ignite Creation Date:
2024-07-17 @ 11:09 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06491862
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-11
Brief Title:
RACE-2L Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
RACE-2L Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy in Brazil
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RACE-2L
Brief Summary:
The study will be implemented as a retrospective noninterventional medical record review of patients from routine practice settings who have been diagnosed with am non-squamous NSCLC with or without AGA and received at least 1 line of systemic treatment after failing PTC between January 2017 and December 2022
Detailed Description:
The study will be implemented as a retrospective noninterventional medical record review of patients from routine practice settings who have been diagnosed with advancedmetastaic non-squamous NSCLC with or without AGA and who have failed platinum-based chemotherapy and immunotherapy for patients without AGA or platinum-based chemotherapy and at least 1 line of targeted therapy for patients with AGA The study will be conducted on one cohort of patients regardless their AGA status The study index date will be defined as first dose of any agent after PTC with specific treatments received for AGA and non-AGA patients in the preindex period We will also conduct a subgroup analysis on NSCLC pre-defined subtypes sample size permitting EGFR mutant ALK translocation ROS1 translocation MET1 mutant HER-2 mutant BRAF mutant pan-wild-type PD-L1 50
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None